Recordati Industria Chimica e Farmaceutica SPA (IT:REC) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Recordati S.p.A. has successfully completed its share buy-back program initiated in May 2024, purchasing over 1.49 million treasury shares, which is 0.714% of its share capital, for approximately 74.7 million Euros. This initiative supports the company’s stock option and performance share plans aimed at enhancing management incentives. Recordati, a globally recognized pharmaceutical group, continues its commitment to providing comprehensive healthcare solutions.
For further insights into IT:REC stock, check out TipRanks’ Stock Analysis page.
